Abstract
Previously, we demonstrated that the coupling of the metabotropic glutamate receptor mGlu1α to phosphoinositide hydrolysis is enhanced by pertussis toxin (PTX) in stably transfected baby hamster kidney cells (BHK). Here, we show that the PTX effect on agonist-stimulated [3H]inositol phosphate accumulation can be resolved into two components: an immediate increase in agonist potency, and a more slowly developing increase in the magnitude of the response observed at maximally effective agonist concentrations. Using Gq/11α- and Gi/oα-selective antibodies to immunoprecipitate [35S]guanosine-5′-O-(3-thio)triphosphate-bound Gα proteins, we also show that agonist stimulation of mGlu1α in BHK membranes increases specific [35S]guanosine-5′-O-(3-thio)triphosphate binding to both Gq/11 and Gi/o proteins. Preincubation of BHK-mGlu1α with l-glutamate (300 μM) results in a progressive loss (60% in 30 min) ofl-quisqualate-induced [3H]inositol phosphate accumulation (without a change in potency), providing evidence for agonist-induced receptor desensitization. Although such desensitization of mGlu receptor signaling was mimicked by a phorbol ester, agonist-induced phosphorylation of the receptor was not observed and protein kinase C inhibition by Ro 31-8220 did not preventl-glutamate-mediated desensitization. In contrast, PTX treatment of the cells almost completely preventedl-glutamate-mediated desensitization. Together, these data provide evidence for a multifunctional coupling of mGlu1α to different types of G proteins, including PTX-sensitive Gi-type G proteins. The latter are involved in the negative control of phospholipase C activity while also influencing the rate of desensitization of the mGlu1α receptor.
Footnotes
- Received January 13, 2000.
- Accepted April 26, 2000.
-
Send reprint requests to: Dr. Emmanuel Hermans, Laboratory of Pharmacology, Catholic University of Louvain (5410), 54 Avenue Hippocrate, 1200 Brussels, Belgium. E-mail:emmanuel.hermans{at}farl.ucl.ac.be
-
This work was supported by the Wellcome Trust of Great Britain (Grant 16895/96). E.H. was a Visiting Research Fellow of the Wellcome Trust (Grant 048460/96) and is now a Senior Research Associate of the FNRS (Belgium). R.S. holds a Medical Research Council Postgraduate Studentship; J.V.S. holds a Biotechnology & Biological Sciences Research Council CASE Studentship sponsored by SmithKline Beecham Pharmaceuticals.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|